Dyne Therapeutics Stock (NASDAQ: DYN) stock price, news, charts, stock research, profile.
You can purchase shares of Dyne Therapeutics (NASDAQ:DYN) through any online brokerage.
Other companies in Dyne Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX), Alkermes (NASDAQ:ALKS) and SpringWorks Therapeutics (NASDAQ:SWTX).
Dyne Therapeutics has a consensus price target of $51.40.
The stock price for Dyne Therapeutics (NASDAQ: DYN) is $29.99 last updated November 20, 2024 at 5:06 PM EST.
There are no upcoming dividends for Dyne Therapeutics.
Dyne Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Dyne Therapeutics.
Dyne Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.